| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA658752 | F | In vitro antimicrobial activity against chlamydia trachomatis. | Chlamydia trachomatis | 1 | ALA1124186 | organism-based format | Scientific Literature | |
| 2. | ALA665160 | F | In vitro antimicrobial activity against chlamydia trachomatis. | Chlamydia trachomatis | 15 | ALA1124186 | organism-based format | Scientific Literature | |
| 3. | ALA957242 | F | Antimicrobial activity against Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model assessed as recovery of inclusion forming units from cervicovaginal swabs at 3 mg/ml, ip administered on days 10 to 24 days postinfection | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 4. | ALA958000 | F | Antimicrobial activity against Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model assessed as recovery of inclusion forming units from cervicovaginal swabs at 3 mg/ml, ip administered on days 42 to 56 days postinfection | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 5. | ALA958001 | F | Antimicrobial activity against Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model assessed as severe oviduct dilation at 3 mg/ml, ip administered on days 10 to 24 days postinfection | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 6. | ALA958002 | F | Antimicrobial activity against Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model assessed as severe oviduct dilation at 3 mg/ml, ip administered on days 42 to 56 days postinfection | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 7. | ALA958003 | F | Effect on chlamydial plasmid DNA of Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model at 3 mg/ml, ip administered on days 10 to 24 days postinfection by nested PCR | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 8. | ALA958004 | F | Effect on chlamydial plasmid DNA of Chlamydia trachomatis Nigg infected in BALB/c mouse genital tract infection model at 3 mg/ml, ip administered on days 42 to 56 days postinfection by nested PCR | Chlamydia trachomatis | 1 | ALA1157374 | organism-based format | Scientific Literature | |
| 9. | ALA1032864 | F | Antibacterial activity against 0.01 MOI wild type Chlamydia trachomatis L2/LGV/434/Bu infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia trachomatis | 6 | ALA1151434 | organism-based format | Scientific Literature | |
| 10. | ALA1032865 | F | Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#23 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia trachomatis | 6 | ALA1151434 | organism-based format | Scientific Literature | |
| 11. | ALA1032866 | F | Antibacterial activity against azithromycin-tolerant 0.01 MOI Chlamydia trachomatis L2AZM#31 harboring mutation in bacterial ribosomal protein L4 infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia trachomatis | 6 | ALA1151434 | organism-based format | Scientific Literature | |
| 12. | ALA1108050 | F | Antibacterial activity against Chlamydia trachomatis infected in human HeLa 229 cells after 35 hrs by fluorescence microscopy | Chlamydia trachomatis | 8 | ALA1156948 | organism-based format | Scientific Literature | |
| 13. | ALA1216839 | F | Antibacterial activity against Chlamydia trachomatis serovar L2 at 50 uM after 5 mins relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 14. | ALA1216840 | F | Antibacterial activity against Chlamydia trachomatis serovar L2 at 50 uM after 120 mins relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 15. | ALA1216841 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 5 mins by MCC assay in presence of simulated vaginal fluid relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 16. | ALA1216842 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 120 mins by MCC assay in presence of simulated vaginal fluid relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 17. | ALA1216843 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 5 mins by MCC assay in presence of simulated seminal fluid relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 18. | ALA1216844 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 120 mins by MCC assay in presence of simulated seminal fluid relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 19. | ALA1216845 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 5 mins by MCC assay in presence of human serum albumin relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature | |
| 20. | ALA1216846 | F | Antibacterial activity against Chlamydia trachomatis serovar D at 60.0 - 3.75 uM after 120 mins by MCC assay in presence of human serum albumin relative to control | Chlamydia trachomatis | 1 | ALA1212805 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!